212 related articles for article (PubMed ID: 21813464)
1. ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Gard JM; Nagle RB; Dietrich JD; Monks TJ; Lau SS
Toxicol Sci; 2011 Nov; 124(1):75-87. PubMed ID: 21813464
[TBL] [Abstract][Full Text] [Related]
2. cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Tham KY; Mastrandrea NJ; Gallegos AC; Monks TJ; Lau SS
Toxicol Sci; 2011 Aug; 122(2):361-71. PubMed ID: 21693435
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional and post-translational modifications of B-Raf in quinol-thioether induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Labenski M; Mastrandrea NJ; Canatsey RD; Monks TJ; Lau SS
Mol Carcinog; 2016 Aug; 55(8):1243-50. PubMed ID: 26333016
[TBL] [Abstract][Full Text] [Related]
4. Transformation of kidney epithelial cells by a quinol thioether via inactivation of the tuberous sclerosis-2 tumor suppressor gene.
Yoon HS; Monks TJ; Walker CL; Lau SS
Mol Carcinog; 2001 May; 31(1):37-45. PubMed ID: 11398196
[TBL] [Abstract][Full Text] [Related]
5. Changes in gene expression during chemical-induced nephrocarcinogenicity in the Eker rat.
Patel SK; Ma N; Monks TJ; Lau SS
Mol Carcinog; 2003 Nov; 38(3):141-54. PubMed ID: 14587099
[TBL] [Abstract][Full Text] [Related]
6. Tuberous sclerosis-2 tumor suppressor modulates ERK and B-Raf activity in transformed renal epithelial cells.
Yoon HS; Ramachandiran S; Chacko MA; Monks TJ; Lau SS
Am J Physiol Renal Physiol; 2004 Feb; 286(2):F417-24. PubMed ID: 14612383
[TBL] [Abstract][Full Text] [Related]
7. Carcinogenicity of a nephrotoxic metabolite of the "nongenotoxic" carcinogen hydroquinone.
Lau SS; Monks TJ; Everitt JI; Kleymenova E; Walker CL
Chem Res Toxicol; 2001 Jan; 14(1):25-33. PubMed ID: 11170505
[TBL] [Abstract][Full Text] [Related]
8. Cell proliferation is insufficient, but loss of tuberin is necessary, for chemically induced nephrocarcinogenicity.
Yoon HS; Monks TJ; Everitt JI; Walker CL; Lau SS
Am J Physiol Renal Physiol; 2002 Aug; 283(2):F262-70. PubMed ID: 12110509
[TBL] [Abstract][Full Text] [Related]
9. Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat.
Habib SL; Phan MN; Patel SK; Li D; Monks TJ; Lau SS
Carcinogenesis; 2003 Mar; 24(3):573-82. PubMed ID: 12663520
[TBL] [Abstract][Full Text] [Related]
10. Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent.
Karbowniczek M; Cash T; Cheung M; Robertson GP; Astrinidis A; Henske EP
J Biol Chem; 2004 Jul; 279(29):29930-7. PubMed ID: 15150271
[TBL] [Abstract][Full Text] [Related]
11. Induction of ERK1/2 and histone H3 phosphorylation within the outer stripe of the outer medulla of the Eker rat by 2,3,5-tris-(glutathion-S-yl)hydroquinone.
Dong J; Everitt JI; Lau SS; Monks TJ
Toxicol Sci; 2004 Aug; 80(2):350-7. PubMed ID: 15129024
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.
Ambrosini G; Cheema HS; Seelman S; Teed A; Sambol EB; Singer S; Schwartz GK
Mol Cancer Ther; 2008 Apr; 7(4):890-6. PubMed ID: 18413802
[TBL] [Abstract][Full Text] [Related]
13. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.
Aziz N; Cherwinski H; McMahon M
Mol Cell Biol; 1999 Feb; 19(2):1101-15. PubMed ID: 9891045
[TBL] [Abstract][Full Text] [Related]
14. Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1.
Distefano G; Boca M; Rowe I; Wodarczyk C; Ma L; Piontek KB; Germino GG; Pandolfi PP; Boletta A
Mol Cell Biol; 2009 May; 29(9):2359-71. PubMed ID: 19255143
[TBL] [Abstract][Full Text] [Related]
15. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 and c-myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK- and ERK-dependent pathway.
Shi Y; Sharma A; Wu H; Lichtenstein A; Gera J
J Biol Chem; 2005 Mar; 280(12):10964-73. PubMed ID: 15634685
[TBL] [Abstract][Full Text] [Related]
17. Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling.
Bhatt KV; Spofford LS; Aram G; McMullen M; Pumiglia K; Aplin AE
Oncogene; 2005 May; 24(21):3459-71. PubMed ID: 15735667
[TBL] [Abstract][Full Text] [Related]
18. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
19. Signaling of extracellular inorganic phosphate up-regulates cyclin D1 expression in proliferating chondrocytes via the Na+/Pi cotransporter Pit-1 and Raf/MEK/ERK pathway.
Kimata M; Michigami T; Tachikawa K; Okada T; Koshimizu T; Yamazaki M; Kogo M; Ozono K
Bone; 2010 Nov; 47(5):938-47. PubMed ID: 20709201
[TBL] [Abstract][Full Text] [Related]
20. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
